T1	Participants 686 781	Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas
T2	Participants 1026 1088	Between February 2003 and July 2005, 25 patients were enrolled
T3	Participants 1090 1179	Nineteen patients were randomised, 9 to the intravenous and 10 to the intra-arterial arms
